DAX
18.274,69 +111,17 (+0,61%) Euro Stoxx 50
4.943,95 +36,65 (+0,75%) Dow Jones 30
39.150,33 +15,53 (+0,04%) Gold
2.339,30 +8,10 (+0,35%) EUR/USD
1,0743 +0,0046 (+0,43%) Bitcoin EUR
56.825,74 -3.075,08 (-5,13%)
BioGaia AB (publ) (BGLAF)
BioGaia AB (publ)
Kungsbroplan 3
Stockholm
Sweden
46 8 555 293 00
https://www.biogaia.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 211
Beschreibung
BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.
Corporate Governance
BioGaia AB (publ)s ISS Governance QualityScore, Stand 1. Juni 2024, lautet 10. Die grundlegenden Scores sind Audit: 10, Vorstand: 9, Shareholderrechte: 8, Kompensation: 9.
